Ksyos Revenue and Competitors

Amstelveen, Netherlands

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ksyos's estimated annual revenue is currently $57M per year.(i)
  • Ksyos's estimated revenue per employee is $297,000

Employee Data

  • Ksyos has 192 Employees.(i)
  • Ksyos grew their employee count by 8% last year.

Ksyos's People

NameTitleEmail/Phone
1
DirectorReveal Email/Phone
2
Coördinator polikliniek SlaapReveal Email/Phone
3
ProductspecialistReveal Email/Phone
4
Productspecialist SlaapReveal Email/Phone
5
AccountmanagerReveal Email/Phone
6
RelatiemanagerReveal Email/Phone
7
ProductspecialistReveal Email/Phone
8
Accountmanager SlaapReveal Email/Phone
9
ImplementatiespecialistReveal Email/Phone
10
Quality EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.5M1023%N/AN/A
#2
$88.8M2996%N/AN/A
#3
$35.9M13323%N/AN/A
#4
$228.2M6767%N/AN/A
#5
$24.8M928%N/AN/A
#6
$66.2M22314%N/AN/A
#7
$71M2393%N/AN/A
#8
$205.2M6083%N/AN/A
#9
$69.8M2356%N/AN/A
#10
$27.5M102-2%N/AN/A
Add Company

What Is Ksyos?

Ksyos is a healthcare institution that focuses on development, research and implementation of telemedicine / eHealth services in mainstream health care. Ksyos works with 7500 general practitioners and 4500 medical specialists and paramedics in e.g. Cardiology, Dermatology, Ophthalmology and Mental Health. Our mission is to improve healthcare accessibility, quality and efficiency by bringing care closer to the patient at lower costs. Website: https://www.ksyos.nl - https://www.ksyos.co.uk Follow Ksyos also on: Twitter | Google+ | Facebook

keywords:N/A

N/A

Total Funding

192

Number of Employees

$57M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ksyos News

2022-04-17 - La plus grande demande du marché mondial de la ...

... avec croissance et analyse des acteurs clés – 3Gen, Ksyos, MetaOptima, 3Derm, VigNet Inc., Érable, MDLIVE Inc., CureSkin.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.8M208-1%N/A
#2
$56.7M22711%N/A
#3
$56.7M22711%N/A
#4
$55.3M305-28%N/A
#5
$83.2M31727%N/A